These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38235404)

  • 1. Human stem cell modeling of neuropsychiatric disorders: from polygenicity to convergence.
    Duan J
    Med Rev (2021); 2023 Aug; 3(4):347-350. PubMed ID: 38235404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells.
    Muhtaseb AW; Duan J
    Schizophr Res; 2022 Apr; ():. PubMed ID: 35459617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease Modeling of Neuropsychiatric Brain Disorders Using Human Stem Cell-Based Neural Models.
    Kaindl J; Winner B
    Curr Top Behav Neurosci; 2019; 42():159-183. PubMed ID: 31407242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New considerations for hiPSC-based models of neuropsychiatric disorders.
    Hoffman GE; Schrode N; Flaherty E; Brennand KJ
    Mol Psychiatry; 2019 Jan; 24(1):49-66. PubMed ID: 29483625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Recapitulation of Neuropsychiatric Disorders with Pluripotent Stem Cells-Derived Brain Organoids.
    Gulimiheranmu M; Li S; Zhou J
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
    van Hugte E; Nadif Kasri N
    Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling neuropsychiatric disorders using human induced pluripotent stem cells.
    Wang M; Zhang L; Gage FH
    Protein Cell; 2020 Jan; 11(1):45-59. PubMed ID: 31134525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities and limitations for studying neuropsychiatric disorders using patient-derived induced pluripotent stem cells.
    Hong Y; Yang Q; Song H; Ming GL
    Mol Psychiatry; 2023 Apr; 28(4):1430-1439. PubMed ID: 36782062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine.
    Novelli G; Spitalieri P; Murdocca M; Centanini E; Sangiuolo F
    Front Cell Dev Biol; 2022; 10():1059579. PubMed ID: 36699015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
    Young JE; Goldstein LSB
    Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies.
    Duan J; Sanders AR; Gejman PV
    J Psychiatr Brain Sci; 2019; 4():. PubMed ID: 31555746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics.
    Matos MR; Ho SM; Schrode N; Brennand KJ
    Mol Cell Neurosci; 2020 Sep; 107():103532. PubMed ID: 32712198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomics analysis of iPSC-derived neurons and modeling of neuropsychiatric disorders.
    Lin M; Lachman HM; Zheng D
    Mol Cell Neurosci; 2016 Jun; 73():32-42. PubMed ID: 26631648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generating CNS organoids from human induced pluripotent stem cells for modeling neurological disorders.
    Brawner AT; Xu R; Liu D; Jiang P
    Int J Physiol Pathophysiol Pharmacol; 2017; 9(3):101-111. PubMed ID: 28694921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convergence of human pluripotent stem cell, organoid, and genome editing technologies.
    Wang L; Ye Z; Jang YY
    Exp Biol Med (Maywood); 2021 Apr; 246(7):861-875. PubMed ID: 33467883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Path from schizophrenia genomics to biology: gene regulation and perturbation in neurons derived from induced pluripotent stem cells and genome editing.
    Duan J
    Neurosci Bull; 2015 Feb; 31(1):113-27. PubMed ID: 25575480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studying Human Neurodevelopment and Diseases Using 3D Brain Organoids.
    Tian A; Muffat J; Li Y
    J Neurosci; 2020 Feb; 40(6):1186-1193. PubMed ID: 32024767
    [No Abstract]   [Full Text] [Related]  

  • 20. Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms.
    Flaherty EK; Brennand KJ
    Brain Res; 2017 Jan; 1655():283-293. PubMed ID: 26581337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.